The biopharma company may also use the proceeds for possible investments in or acquisitions of complementary businesses or technologies.
Other competitors in the healthcare sector include: PDL BioPharma Inc. (PDLI), Abbott Laboratories (ABT), and Bristol Myers Squibb (BMY).
Developed by tiny biotech firm Galena Biopharma (GALE), Neu Vax is now in the initial phases of a third clinical study that.
FORBES: Roche Accelerates Defense Strategy to Protect Breast-Cancer Drug Herceptin's Turf
This piece, discussing the contrasting characteristics of a representative tech healthcare start-up and a biopharma start-up, and highlighting which each might learn from the other.
FORBES: Are doctors over-responsive to patients -- or not attentive enough? (Answer: yes.)
He has been involved in a long-running legal fight with Philadelphia-based Hemispherx Biopharma, maker of a chronic fatigue syndrome drug that he believes is snake oil.
He expects more strategic deals, although his poll found the average number of CROs used will drop by 6.5 percent this year to 5 for each biopharma.
FORBES: Whither Contract Research Organizations: A Glass Half Full?
In recent years, biopharma executives have been falling over each other to convince investors that they really and truly understand the rising importance of payor pressure and payor power.
FORBES: Penic(illin) envy: is incremental progress systematically undervalued?
Sarepta, formerly known as AVI Biopharma, boomed because of data from an 8-patient study that shows unprecedented efficacy for its drug, eteplirsen, dramatically reduced the rate at which patients with Duchenne muscular dystrophy worsened.
FORBES: Sarepta Outperformed Biotechs In August Due To Muscular Dystrophy Drug
Today, innovators in academia, biopharma companies and governmental agencies are increasingly working together in real-time, and finding new ways to deploy their strengths to solve serious medical challenges that no one actor can solve alone.
FORBES: Guest Post: Pfizer Research Boss On Why He's Working With The Cystic Fibrosis Foundation
Similarly in business, if a senior biopharma executive was forced every day to step through even of fraction of the actual complexity of the science associated with every product, it would be overwhelming, and make decision-making all but impossible.
FORBES: Leaders Of Science-Driven Businesses Should Understand...Science
The new outfit, Transcelerate Biopharma, was created out of a regular meeting of drug company research chiefs and will focus on five areas where the clinical trials that are used to test medicines wastefully duplicate procedures like training physicians, running websites, or creating procedures to document the benefits and side effects of new medicines.
FORBES: Ten Pharmas Aim To Cut Red Tape To Speed Drug Development
This will be a familiar dialog not only to investors but also to those in biopharma (who perhaps should be thought of as investors as well), as they continuously need to decide whether to go for a risky potential blockbuster or more of a sure-thing that ostensibly may be associated with a smaller market.
应用推荐